We Work For Health Applauds Trump Administration's Focus on Insurance Industry Reform

WASHINGTON, D.C. (Dec. 29, 2025) – We Work For Health commends the Trump administration for recognizing the substantial role corporate insurers and their integrated subsidiaries play in driving up costs and restricting access to care for American families. The administration's announcement of their intent to bring healthcare insurance executives to the table and examine the full scope of insurance industry practices represents the most necessary and critical step toward meaningful cost savings and pricing reform.

We applaud the Centers for Medicare and Medicaid’s recent announcement of new healthcare transparency rules and encourage the administration to continue to tackle the anti-competitive practices of corporate insurers and their subsidiary pharmacy benefit managers (PBMs). These corporations rely on complex, deliberately opaque business practices that are fundamental drivers of inflated costs throughout the entire healthcare system.

Mega insurers have built empires through the creation or acquisition of PBMs, pharmacy chains, physician practices, foreign domiciled drug manufacturing entities and data analytics firms, creating vertically integrated structures that today control every aspect of healthcare spending while evading any degree of reasonable accountability. When insurers control the PBMs that negotiate drug prices, the pharmacies that dispense medications, the healthcare providers that prescribe the medication and the data firms that control access to critical information, costs will continue to rise and American families suffer the consequences.

We Work For Health stands ready to work with the administration and Congress to pursue reforms that hold insurance companies and PBM middlemen accountable. American families, workers and businesses deserve a healthcare system that prioritizes their needs over the financial interests of Big Insurance.